Tocotrienols: Clinical Trials

23 trials of Tocotrienols, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 4 unknown, 2 active not recruiting, 2 withdrawn. 14 Phase 2, 5 Phase 3, 3 Not applicable, 2 Phase 1, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 214Completed 9, Active not recruiting 2, Withdrawn 2, Unknown 1
Phase 35Completed 2, Terminated 1, Unknown 1, Withdrawn 1
Not applicable3Completed 2, Unknown 1
Phase 12Active not recruiting 1, Withdrawn 1
Early Phase 11Completed 1

Follow Tocotrienols: new trials by email Literature Review of Tocotrienols trials Research Report on Tocotrienols

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL)
Tocotrienols / Vitamin E, Placebo control - Hepatic Steatosis, NAFLD
Phase 2CompletedYuen Kah Hay1702021-01-012024-05-10
Efficacy and Safety of Tocotrienols in CADASIL
HOV-12020 (Palm tocotrienols complex), Placebo - Cadasil
Phase 2CompletedHovid Berhad502020-12-212026-02-02
Tocotrienol and Bevacizumab in Metastatic Colorectal Cancer
Fluorouracil, Calcium folinate, Oxaliplatin - Colorectal Cancer Metastatic
Phase 2Active not recruitingVejle Hospital832020-06-262026-04-03
Tocotrienol Against the Progression of End Stage Liver Disease
Tocotrienol (TCT), Placebo - End Stage Liver Disease, NASH - Nonalcoholic Steatohepatitis
Phase 2CompletedChandan Sen1102019-11-012026-09-08
Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer
Bevacizumab, Tocotrienol - Ovarian Cancer Recurrent
Phase 2CompletedVejle Hospital202019-10-292025-01-03
The Efficacy and Safety of Vitamin E Mixed Tocotrienols In Patients With Amyotrophic Lateral Sclerosis (ALS)
Tocotrienols, Placebo - Amyotrophic Lateral Sclerosis
Phase 2UnknownUniversity of Malaya202019-06-172019-10-25
Tocotrienols for Skeletal Muscle Health
placebo softgel, DeltaGoldĀ® Tocotrienol 70% - Dynapenia, Postmenopausal Women
Phase 1 / Phase 2WithdrawnTexas Tech University Health Sciences Center2019-04-152022-02-18
Tocotrienols for Obesity of Postmenopausal Women
placebo softgel, DeltaGoldĀ® Tocotrienol 70% - Obesity, Postmenopausal Women
Phase 1 / Phase 2Active not recruitingTexas Tech University Health Sciences Center602019-03-152026-10-02
Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation
Tocotrienols, Placebo oral capsule - Atrial Fibrillation
Phase 2 / Phase 3CompletedMonash University Malaysia2502018-12-172022-08-25
Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer
Epirubicin 90 mg/m2 iv, Cyclophosphamide 600 mg/m2 iv, Docetaxel 100 mg/m2 iv OR paclitaxel 80 mg/m2 iv - Breast Cancer
Phase 2CompletedVejle Hospital802016-09-142021-05-20
Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer
Irinotecan 165 mg/m2 iv, Oxaliplatin 85 mg/m2 iv, Calcium folinate 200 mg/m2 iv - Colorectal Cancer
Phase 2CompletedVejle Hospital702016-05-062024-08-29
Preoperative Use of Tocotrienol From Annatto Bixa Orellana L. in Breast Cancer Patients: a Prospective Clinical Trial.
Tocotrienol - Breast Cancer
Phase 2CompletedFondazione IRCCS Istituto Nazionale dei Tumori, Milano502016-02-092020-08-03
Tocotrienol as a Nutritional Supplement in Patients With Advanced Lung Cancer
Day 1: Cisplatin 75 mg/m2, Day 1: Vinorelbine 25 mg/m2, Day 8: Capsule vinorelbine 50 mg/m2 - Lung Cancer
Phase 3TerminatedVejle Hospital792016-01-012021-05-03
Stroke and Tocotrienol: Unique Role in Neuroprotection
Tocotrienol, Placebo capsules - Ischemic Stroke
Phase 3UnknownSeberang Jaya Clinical Research Centre1502015-07-012018-02-13
Effects of a Supplement Derived From Palm Oil on Cholesterol Levels and Chinese Red Yeast Rice in the Blood
Sugar Pill, Chinese Red Yeast Rice (CRYR), CRYR + TRF - Cholesterol Lowering
Phase 2 / Phase 3WithdrawnUniversity of California, Los Angeles2013-10-302019-01-11
Nutrition Blood Outcomes Following Tocotrienol N2B
Tocotrienol Capsules, Placebo Vehicle - Stroke
CompletedOhio State University3002013-03-012021-09-20
Efficacy Of Tocotrienol a Natural Vitamin E In Biopsy Wound
Topical Tocotrienol (TCT), Oral Tocotrienol Capsules (TCT), Tamoxifen Cream - Scar
UnknownChandan K Sen1012012-01-012018-01-29
Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF)
ECGC, Tocotrienol, EGCG + Tocotrienol - Cystic Fibrosis
Not applicableCompletedHadassah Medical Organization72011-11-012017-11-30
Neuroprotection by Tocotrienols in Type 1 and Type 2 Diabetes Mellitus
Tocotrienol, Placebo - Diabetic Neuropathy, Cognitive Impairment
Phase 3CompletedUniversiti Sains Malaysia3002011-06-012017-05-04
Study of Tocotrienol Absorption and Distribution Under Different Fat Status
Tocotrienol - Absorption
Not applicableCompletedMalaysia Palm Oil Board102009-09-012010-08-20

Showing 20 of 23. Sign in to see all of them.

Conditions studied

Stroke (3)  ·  Breast Neoplasms (2)  ·  Cerebrovascular Disorders (2)  ·  Cognitive Dysfunction (2)  ·  Colorectal Neoplasms (2)  ·  End Stage Liver Disease (2)  ·  Fatty Liver (2)  ·  Non-alcoholic Fatty Liver Disease (2)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Atrial Fibrillation (1)  ·  CADASIL (1)  ·  Carotid Stenosis (1)  ·  Cerebral Small Vessel Diseases (1)  ·  Cicatrix (1)  ·  Cystic Fibrosis (1)

Sponsors

Vejle Hospital (5)  ·  Chandan K Sen (2)  ·  Texas Tech University Health Sciences Center (2)  ·  Universiti Sains Malaysia (2)  ·  Chandan Sen (1)  ·  Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1)  ·  Hadassah Medical Organization (1)  ·  Hovid Berhad (1)  ·  Malaysia Palm Oil Board (1)  ·  Mid-Atlantic Retina Consultations, Inc. (1)  ·  Monash University Malaysia (1)  ·  Ohio State University (1)  ·  Seberang Jaya Clinical Research Centre (1)  ·  University of California, Los Angeles (1)  ·  University of Malaya (1)

Countries

United States (8)  ·  Malaysia (7)  ·  Denmark (5)  ·  France (1)  ·  Israel (1)  ·  Italy (1)

Top investigators

Chwan-Li Shen, PhD (2)  ·  Kah Hay Yuen, PhD (2)  ·  Ahmad Farouk Musa, MD (1)  ·  Chandan K Sen, Ph.D (1)  ·  Chandan K Sen, PhD (1)  ·  Chandan Sen, PhD (1)  ·  Christa H Nyhus, MD (1)  ·  Cristina Ferraris, MD (1)  ·  David Ho (1)  ·  Eitan Kerem, MD (1)  ·  Erik H Jakobsen, MD (1)  ·  Lars H Jensen, PhD (1)  ·  Louise R Larsen, MD (1)

Results publications

PMID 10227040, PMID 10574414, PMID 10964265, PMID 11160563, PMID 11206194, PMID 11516635, PMID 11882333, PMID 11893482, PMID 11999415, PMID 12881019, PMID 1433170, PMID 14566071, PMID 14698044, PMID 14747214, PMID 15035006, PMID 15203383, PMID 15498784, PMID 15569611, PMID 15723336, PMID 15746970, PMID 15753141, PMID 15792944, PMID 15823271, PMID 16008108, PMID 16159610, PMID 16249550, PMID 16275870, PMID 16450399, PMID 16458936, PMID 16645729, PMID 16831864, PMID 17109639, PMID 18081943, PMID 18452640, PMID 18490840, PMID 18599020, PMID 18806966, PMID 19035289, PMID 19066370, PMID 19071006, PMID 19121919, PMID 19142032, PMID 19346993, PMID 19491296, PMID 19702331, PMID 19732602, PMID 2012015, PMID 20188744, PMID 20306477, PMID 20493172

NIH funding

2014 (1)